YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE
The funds will be used to further develop YGION's innovative YGNITE™ technology platform and advance their lead program, YG-01, into preclinical and clinical stages.
YGION Biomedical | 21/05/2024 | By Abha | 225
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy